ANTIBODY-DRUG CONJUGATES THAT BIND TO NaPi2b
AR135650A1Pending Publication Date: 2026-10-14MERCK PATENT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100889
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-04-04
- Filing Date
- 2025-04-04
- Publication Date
- 2026-10-14
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
The present invention relates to ADCs that are joined to NaPi2b.
1. Antibody-drug conjugate (ADC), wherein the ADC is a compound of formula (1), wherein n is the number of [(linker) – (exatec)] fragments covalently bound to the antibody; and wherein n is preferably between 1 and 10 and more preferably around 4, and the antibody is bound to NaPi2b.
3. A pharmaceutical composition comprising the ADC of claim 1 or 2.